After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs that could offer rare hope to patients given this particularly deadly diagnosis.
Apr 22, 2026
0
27
Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from Spain's National Cancer Research Centre (CNIO) has been able to avoid the development of resistance ...
Feb 3, 2026
0
90
Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis.
Jan 5, 2026
0
111
New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and activate the immune system, offering the first targeted approach for patients with NRAS-mutant melanoma, ...
Nov 4, 2025
0
16
HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new treatment for pancreatic cancer, one of the most aggressive and difficult to treat of all malignancies.
Apr 29, 2025
0
21
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer than the same targeted therapy ...
Mar 14, 2025
0
41
